Evidence map›Paper›PMID 39791825›Full record

ReviewNanomaterials (Basel, Switzerland)2025

Stefania Villani, Matteo Calcagnile, Christian Demitri, Pietro Alifano

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. DecipheringMicrobiology spectrum · 2025
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stefania VillaniDepartment of Engineering for Innovation, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-2562-4341
Matteo CalcagnileDepartment of Experimental Medicine, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-9745-4583
Christian DemitriDepartment of Experimental Medicine, University of Salento, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-1145-6674
Pietro AlifanoDepartment of Experimental Medicine, University of Salento, Via Monteroni, 73100 Lecce, Italy.

Funding

Italian Ministry of Research Ministerial Decree n. 351/2022 - PNRR Mission 4, Component 1
6 · The paper itself

Abstract

The spread of multidrug-resistant microbes has made it necessary and urgent to develop new strategies to deal with the infections they cause. Some of these are based on nanotechnology, which has revolutionized many fields in medicine. Evaluating the safety and efficacy of these new antimicrobial strategies requires testing in animal models before being tested in clinical trials. In this context,

Indexed as

Galleria mellonellain vivo modelmultidrug-resistant microbesnanocompositesnanoparticlestoxicity

Identifiers

PMID39791825
PMCPMC11723170

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.